Physician
Oncology
Dr. Jason Westin, MD
|
|
Give Review
Jason Westin is an expert in the field of Oncology. He went to University of Florida College of Medicine. University of Florida College of Medicine is ranked 43/78 in Research/PrimaryCare. Jason Westin, MD has written publications. He has 18 publications published with PubMed. The lastest publication is: 'Doxorubicin-Based Chemotherapy and Radiation Therapy Produces Favorable Outcomes in Limited-Stage Plasmablastic Lymphoma: A Single-Institution Review.' Jason Westin is registered with Medicare and accepts Medicare payments.
Publications
- Doxorubicin-Based Chemotherapy and Radiation Therapy Produces Favorable Outcomes in Limited-Stage Plasmablastic Lymphoma: A Single-Institution Review.
- Benefit of Consolidative Radiation Therapy for Primary Bone Diffuse Large B-Cell Lymphoma.
- Experience with HSP90 inhibitor AUY922 in patients with relapsed or refractory non-Hodgkin Lymphoma.
- Multimodality imaging of Epstein-Barr virus-associated inflammatory pseudotumor-like follicular dendritic Cell tumor of the spleen: case report and literature review.
- A clinician's guide to double hit Lymphomas.
- Safety and activity of lenalidomide and rituximab in untreated indolent Lymphoma: an open-label, phase 2 trial.
- Paclitaxel, topotecan and rituximab: long term outcomes of an effective salvage programme for relapsed or refractory aggressive B-cell non-Hodgkin Lymphoma.
- Combination of ibrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) for treatment-naive patients with CD20-positive B-Cell non...
- Double hit lymphoma: the MD Anderson Cancer Center clinical experience.
- Busting robustness: using Cancer's greatest strength to our advantage.
- Status of PI3K/Akt/mTOR Pathway Inhibitors in Lymphoma.
- Safety and activity of PD1 blockade by pidilizumab in combination with rituximab in patients with relapsed follicular Lymphoma: a single group, open-label, phase 2 trial.
- Could treatment with R-HCVAD/R-MA as compared to R- CHOP truly result in improved outcomes for patients with high-risk diffuse large B cell Lymphoma? - Response to Lan...
- Prospective phase II study of rituximab with alternating cycles of hyper-CVAD and high-dose methotrexate with cytarabine for young patients with high-risk diffuse larg...
- R-CHOP every 21 days for diffuse large B-cell Lymphoma: still the standard of care?
- Zoledronic acid for prevention of bone loss in patients receiving primary therapy for Lymphomas: a prospective, randomized controlled phase III trial.
- A single case of rosai-dorfman Disease marked by pathologic fractures, kidney failure, and liver cirrhosis treated with single-agent cladribine.
Schools
Univ Of Fl Coll Of Med
Procedures Preformed
- Plasmapheresis
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Anemia
- Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
- Brain Cancer
- View All
Doctors Specialties
- Medical Oncology
- Oncology
Accepted Insurances
Education
-
University of Texas Health Science Center -
University of North Carolina Hospitals -
University of Florida College of Medicine
Hospital
-
University of Texas M.D. Anderson Cancer Center
Drug Facts
| NPI NUMBER | 1972615102 | |
| NPPES Provider LastName | WESTIN | |
| NPPES Provider FirstName | JASON | |
| NPPES Provider ZIPCode | 770304008 | |
| NPPES Provider State | TX | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 203.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 17.0 | |
| Percent Opioid Claims | 8.37 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1972615102 |
| Last Name Of The Provider | WESTIN |
| First Name Of The Provider | JASON |
| View All |
Similar Doctors
|
Dr. Paul Zhang, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jeong H. Oh, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniel J. Booser, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Anita Sabichi, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Francisco J. Esteva, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Nikesh Jasani, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John C. Araujo, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Sewa S. Legha, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Issa F. Khouri, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Sumit K. Subudhi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Waun K. Hong, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Milind Javle, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. An N. Hoang, MD |
|
|
Dr. Maria A. Scouros, MD
This Doctor is OpenDoctor Recommended.
|